Literature DB >> 18788218

Reduction of blood coagulation and monocyte-platelet interaction following the use of a minimal extracorporeal circulation system (Synergy) in coronary artery bypass grafting (CABG).

P A Farneti1, S Sbrana, D Spiller, A G Cerillo, F Santarelli, D Di Dario, P A Del Sarto, M Glauber.   

Abstract

Cardiovascular surgery with cardiopulmonary bypass (CPB) induces activation of blood coagulation and systemic inflammation involved in post-operative complications. Our study evaluated the impact of the minimal extracorporeal circulation (mini-CPB) system (Synergy, Sorin Group) on these functional aspects. Twenty patients were randomly assigned to standard CPB (n = 10) or to Synergy (n = 10). Platelet expression of PAC-1, and monocyte/granulocyte-platelet conjugates were evaluated by flow cytometry. A leukocyte-platelet adhesion index was calculated after cell number normalization. ELISAs were performed to measure IL-6 and TNF-alpha, thrombin-antithrombin III complexes (TAT), prothrombin fragments (F1+2), beta-thromboglobulin (beta-TG) and sP-selectin (sCD62P). Blood samples were drawn at the time of anesthesia (T1), at the end of CPB (T2), and at 4 (T3) and 24 hours (T4) after weaning from CPB. All patients were similar for clinical characteristics. When compared to standard CPB, the Synergy showed lower levels of the monocyte-platelet adhesion index at T2 (0.023 +/- 0.005 vs 0.063 +/- 0.013, P = 0.0092) and T4 (0.031 +/- 0.003 vs 0.055 +/- 0.005, P = 0.0017), TAT complexes at T2 (27.175 +/- 5.967 vs 86.592 +/- 5.415, P = 0.0005) and T3 (26.977 +/- 2.468 vs 45.146 +/- 4.365, P = 0.0041), F1+2 fragments at T2 (2.222 +/- 0.226 vs 4.249 +/- 0.292, P = 0.0009), and sP-selectin at T3 (115.17 +/- 19.623 vs 169.554 +/- 19.709, P = 0.0703) and T4 (108.542 +/- 6.429 vs 140.799 +/- 14.771, P = 0.0833). In summary, the Synergy exhibited a lower post-operative activation of blood coagulation, together with a reduced interaction between circulating monocytes and platelets.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18788218     DOI: 10.1177/0267659108091336

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  4 in total

Review 1.  A review of antiplatelet drugs, coronary artery diseases and cardiopulmonary bypass.

Authors:  Yajun Ren; Kirti Patel; Terry Crane
Journal:  J Extra Corpor Technol       Date:  2010-06

2.  Impact of minimally invasive extracorporeal circulation on coagulation-a randomized trial.

Authors:  Ivy Susanne Modrau; Debbie Richards Halle; Per Hostrup Nielsen; Hans Henrik Kimose; Jacob Raben Greisen; Michael Kremke; Anne-Mette Hvas
Journal:  Eur J Cardiothorac Surg       Date:  2020-06-01       Impact factor: 4.191

Review 3.  Inflammation and Oxidative Stress in the Context of Extracorporeal Cardiac and Pulmonary Support.

Authors:  Sanaz Hatami; Joshua Hefler; Darren H Freed
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

Review 4.  The inflammatory response to miniaturised extracorporeal circulation: a review of the literature.

Authors:  Hunaid A Vohra; Robert Whistance; Amit Modi; Sunil K Ohri
Journal:  Mediators Inflamm       Date:  2010-01-13       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.